-
DAWN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Day One Biopharmaceuticals (DAWN)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 422.77 mm | 422.77 mm | 422.77 mm | 422.77 mm | 422.77 mm | 422.77 mm |
Cash burn (monthly) | (no burn) | (no burn) | (no burn) | 17.62 mm | (no burn) | 7.46 mm |
Cash used (since last report) | n/a | n/a | n/a | 70.88 mm | n/a | 29.99 mm |
Cash remaining | n/a | n/a | n/a | 351.89 mm | n/a | 392.77 mm |
Runway (months of cash) | n/a | n/a | n/a | 20.0 | n/a | 52.7 |
13F holders | Current |
---|---|
Total holders | 166 |
Opened positions | 36 |
Closed positions | 24 |
Increased positions | 66 |
Reduced positions | 36 |
13F shares | Current |
---|---|
Total value | 1.24 tn |
Total shares | 112.05 mm |
Total puts | 217.50 k |
Total calls | 143.70 k |
Total put/call ratio | 1.5 |
Largest owners | Shares | Value |
---|---|---|
AI Day 1 | 12.93 mm | $183.21 mm |
Ra Capital Management | 7.87 mm | $109.65 bn |
FMR | 7.41 mm | $103.25 bn |
Atlas Venture Life Science Advisors | 6.43 mm | $89.57 bn |
Vanguard | 5.89 mm | $82.01 bn |
Braidwell | 4.87 mm | $67.89 bn |
Atlas Venture Fund XI | 4.87 mm | $70.46 mm |
BlackRock | 4.71 mm | $65.60 bn |
BEN Franklin Resources | 3.87 mm | $55.34 bn |
Fairmount Funds Management | 3.10 mm | $43.23 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Dec 24 | Samuel C. Blackman | Common Stock | Sell | Dispose S | No | Yes | 13.3113 | 30,000 | 399.34 k | 1,034,015 |
18 Nov 24 | Dubow Adam | Common Stock | Sell | Dispose S | No | No | 13.2102 | 3,165 | 41.81 k | 32,162 |
18 Nov 24 | Charles N York II | Common Stock | Sell | Dispose S | No | No | 13.2102 | 2,602 | 34.37 k | 240,133 |
18 Nov 24 | Jeremy Bender | Common Stock | Sell | Dispose S | No | No | 13.2102 | 10,554 | 139.42 k | 108,377 |
18 Nov 24 | Samuel C. Blackman | Common Stock | Sell | Dispose S | No | No | 13.2102 | 2,206 | 29.14 k | 1,064,015 |
15 Nov 24 | Dubow Adam | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,687 | 0.00 | 35,327 |
15 Nov 24 | Dubow Adam | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,750 | 0.00 | 31,640 |
15 Nov 24 | Dubow Adam | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,962 | 0.00 | 29,890 |
15 Nov 24 | Dubow Adam | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,687 | 0.00 | 44,252 |
15 Nov 24 | Dubow Adam | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,750 | 0.00 | 14,000 |